Global Endocrine Testing Market – Industry Trends and Forecast to 2028

Global Endocrine Testing Market, Test (Thyroid Test, Insulin Test, Dehydroepiandrosterone sulfate (DHEAS), Human Chorionic Gonadotropin Test, Human Chorionic Gonadotropin (HCG), Follicle Stimulating (FSH), Prolactin Test, Luteinizing Hormone Test, Progesterone Test, and Others), Technology (Immunoassay, Monoclonal and Polyclonal Antibody Technologies, Clinical Chemistry Technologies, Tandem Mass Spectroscopy, Sensor Technology, and Others), End-User (Hospitals, Clinical Laboratories, and Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.

Market Analysis and Insights: Global Endocrine Testing Market

Global endocrine testing market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 9,067.33 million in 2020 to USD 14,321.57 million by 2028 growing at a CAGR of 5.88% in the above-mentioned forecast period.

The endocrine system basically comprises of the endocrine glands such as the pituitary, thyroid, pancreas, adrenal among others. The endocrine testing is basically conducted to find out the levels of various hormones, check function of endocrine glands, cause of an endocrinological problem or an earlier diagnosis.

The growing prevalence of endocrine disorders and other diseases such as obesity, diabetes, thyroid disease and others, sedentary lifestyle, unhealthy diet and increasing aged population is primarily responsible for driving the growth of the endocrine testing market. The increasing health awareness around the world, and the advancement in products with easy operating home diagnostic kits which are cost-effective and designed with precision is expected to generate new opportunities for the market. On the other hand, the high cost of advanced endocrine testing products might restrain the overall growth of the market. The heavy investment and advancements in product technologies is estimated to generate new opportunities within the forecast period. However, the factors such as lack of awareness in underdeveloped and developing regions is projected to be a major challenge for the market’s growth.

This endocrine testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research endocrine testing market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Endocrine Testing Market Scope and Market Size

Endocrine testing market is segmented on the basis of test, technology and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of test, the endocrine testing market is bifurcated into thyroid test, insulin test, dehydroepiandrosterone sulfate (DHEAS), human chorionic gonadotropin test, human chorionic honadotropin (HCG), follicle stimulating (FSH), prolactin test, luteinizing hormone, progesterone test and others.
• On the basis of technology, the endocrine testing market is segmented into immunoassay, monoclonal and polyclonal antibody technologies, clinical chemistry technologies, tandem mass spectroscopy, sensor technology and others.
• On the basis of end-user, the endocrine testing market is segmented into hospitals, clinical laboratories and others.

Endocrine Testing Market Country Level Analysis

Endocrine testing market is analysed and market size insights and trends are provided by test, technology and end users as referenced above.

The countries covered in the endocrine testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the endocrine testing market due to the high prevalence of obesity and advancements in diagnostic technologies and development of innovative easy-to-operate test kits within the region. Asia-Pacific is expected to grow at the fastest rate in the forecast period of 2021 to 2028 due to increasing number of patients suffering from endocrine disorders and increasing government initiatives for improvement of healthcare facilities.

The country section of the endocrine testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Endocrine testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for endocrine testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the endocrine testing market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Endocrine Testing Market Share Analysis

Endocrine testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to endocrine testing market.

The major players covered in the endocrine testing market report are Abbott, DH Tech. Dev. Pte. Ltd.,  Biomedical Technologies Limited, Agilent, Beckman Coulter, Inc.,  bioMérieux SA, Bio Rad Laboratories Inc., DiaSorin, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings., Quest Diagnostics Incorporated,  Hologic, Inc., Ortho Clinical Diagnostics, QIAGEN, American Chemistry Council, Inc., among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.